Master amylase and lipase in acute and chronic pancreatitis. Understand macroamylasemia for ASCP BOC MCQs. ย
ASCPprep.com | Clinical Chemistry
Chapter 12 โ Pancreatic, Gastric & Intestinal Function
ASCP Board Exam ยท Lab-Focused Study Guide
Methods ยท Clinical Interpretation ยท Pre-analytical Variables ยท Practice Questions
SECTION 1 โ Priority Table & Quick Foundation
| Topic | Priority | Why It’s Tested |
|---|---|---|
| Acute pancreatitis โ amylase & lipase timing | HIGH | Classic case-based question; diagnostic window separates passing from failing students. |
| Cystic fibrosis โ sweat chloride / pilocarpine iontophoresis | HIGH | Pediatric scenario; chromosome 7 / CFTR; cutoff >60 mmol/L. |
| Zรถllinger-Ellison syndrome โ gastrin + secretin test | HIGH | Paradoxical rise of gastrin after secretin; basal/max ratio >60%. |
| d-Xylose test (intestinal vs pancreatic malabsorption) | HIGH | Best discriminator โ examiners love this one. |
| Macroamylasemia vs acute pancreatitis (Cam/Ccr ratio) | HIGH | Confusing pair; direction of ratio is exam favorite. |
| Fecal elastase-1 (pancreatic insufficiency) | HIGH | Modern non-invasive method of choice โ unaffected by enzyme replacement. |
| Celiac disease โ TGA-IgA, HLA-DQ2 | HIGH | Autoantigen = tissue transglutaminase; always check total IgA first. |
| Fecal calprotectin (IBD vs IBS) | HIGH | S100 family; sensitive for organic GI inflammation. |
| Lactose hydrogen breath test (lactase deficiency) | MEDIUM | Replaced lactose tolerance test; rise >20 ppm = positive. |
| H. pylori โ urea breath test (ยนยณC) | MEDIUM | Urease activity; stop PPI ≥2 weeks before. |
| GI regulatory peptides (CCK, secretin, VIP, GIP, gastrin) | MEDIUM | Source cells & functions; WDHA syndrome = VIPoma. |
| Fecal fat (Sudan III vs 72-h gravimetric) | MEDIUM | Qualitative vs quantitative; 72-h collection on 100 g/d fat diet. |
| Pernicious anemia โ intrinsic factor | MEDIUM | Parietal cell loss โ gastric pH won’t drop below 6 even with stimulation. |
| Bile acid malabsorption (SeHCAT, C4, FGF-19) | LOW | Niche but emerging โ know the markers exist. |
| Rare disaccharidase deficiencies (trehalase, sucrase-isomaltase) | LOW | Occasionally appears; mushroom intolerance = trehalase. |
๐ฏ Where to focus: Master the HIGH rows first โ every one of them appears in the practice quiz and the rapid revision sheet. SKIM the LOW rows; you only need to recognize the term, not the mechanism. The single most testable concept in this chapter is the amylase/lipase pattern in acute pancreatitis plus the d-xylose test for localizing malabsorption.
Quick Foundation โ for the first-time reader
- The pancreas has two jobs: endocrine (insulin, glucagon, gastrin, somatostatin from islets) and exocrine (digestive enzymes + bicarbonate from acinar cells into the duodenum).
- Pancreatic juice is alkaline (pH up to 8.3) because of bicarbonate โ it neutralizes stomach acid entering the duodenum.
- Two hormones control pancreatic output: Secretin (acid in duodenum โ bicarbonate-rich juice) and CCK (fats/amino acids in duodenum โ enzyme-rich juice).
- The stomach secretes HCl + intrinsic factor (parietal cells), pepsin (chief cells), and gastrin (G cells in antrum).
- The small intestine does most digestion and absorption; villi + microvilli increase surface area ~600-fold (โ250 mยฒ).
- Malabsorption = failure to take nutrients into the body. It can come from the pancreas (no enzymes), bile (no emulsification), or the small bowel (damaged mucosa). d-Xylose is the test that tells you which.
- Steatorrhea = fat in stool >5 g/24 h. It is the visible signal of fat malabsorption.
๐ณ Analogy that makes it click: Think of digestion as a restaurant. The stomach is the prep station (acid + pepsin chop proteins coarsely). The pancreas is the kitchen (lipase, amylase, proteases finish cooking everything). The small intestine is the dining room (villi absorb the finished meal). A problem at any station ruins the meal โ and the d-xylose test tells you whether the kitchen (pancreas) or the dining room (intestine) is broken, because d-xylose doesn’t need the kitchen at all โ it walks straight into the dining room.
Why this matters clinically: Patients with malabsorption all look the same โ bulky stools, weight loss, anemia. The lab’s job is to localize the lesion, because pancreatic insufficiency is treated with enzyme replacement while intestinal disease (e.g., celiac) is treated with a gluten-free diet โ completely different interventions.
| Concept | Plain-English Explanation |
|---|---|
| Endocrine vs exocrine pancreas | Endocrine = hormones into blood (insulin etc.). Exocrine = enzymes into the gut (lipase etc.). |
| Why amylase rises in pancreatitis | Acinar cells are damaged; enzymes leak into blood. |
| Why hypocalcemia in pancreatitis | Free fatty acids (made by released lipase) grab calcium โ calcium “soap” โ serum Ca drops. |
| Why d-xylose distinguishes pancreas from intestine | It’s a pentose absorbed directly by the small bowel โ needs no enzymes. Low absorption = bowel problem. |
| Why sweat chloride is high in CF | Mutant CFTR channel can’t reabsorb chloride from sweat ducts. |
| Why fecal elastase > fecal chymotrypsin | Elastase isn’t degraded in transit AND isn’t affected by oral enzyme supplements (uses anti-human Ab). |
SECTION 2 โ Core Content Tables
2.1 Pancreas โ Anatomy & Secretory Physiology
| Feature | Details |
|---|---|
| Size / weight | ~12โ15 cm long; 70โ105 g. Head sits in the duodenal curve; tail extends to the spleen. |
| Exocrine output | 1.5โ2 L/day (can reach 3 L); colorless, alkaline (pH up to 8.3), specific gravity 1.007โ1.042. |
| Endocrine output | Islets of Langerhans โ insulin (ฮฒ), glucagon (ฮฑ), gastrin, somatostatin. |
| Acinar cells | Produce zymogens (trypsinogen, chymotrypsinogen) + active enzymes (amylase, lipase). |
| Duct anatomy | Main pancreatic duct + common bile duct โ ampulla of Vater โ sphincter of Oddi โ duodenum. |
| Bicarbonate + Clโป | Reciprocally balanced; total โ 150 mmol/L. Naโบ and Kโบ similar to serum. |
| Enzyme classes | Proteolytic (trypsin, chymotrypsin, elastase, carboxypeptidases) ยท Lipolytic (lipase, lecithinase, colipase) ยท Amylolytic (ฮฑ-amylase) ยท Nucleases. |
| Activation cascade | Enterokinase (duodenal brush border) cleaves trypsinogen โ trypsin โ activates ALL other zymogens. |
KEY: Secretin (from duodenal S cells) is released by acid โ tells pancreas to send bicarbonate-rich watery juice. CCK (from duodenal I cells) is released by fat/amino acids โ tells pancreas to send enzyme-rich juice. Memorize: “Acid asks for buffer, fat asks for enzymes.”
2.2 Amylase โ The Pancreatitis Marker
| Feature | Details |
|---|---|
| Definition | ฮฑ-amylase hydrolyzes starch โ maltose / dextrins. Two isoforms: salivary (S) and pancreatic (P). |
| Tissue source | Pancreas (acinar cells) and salivary glands. |
| Mechanism of elevation | Acinar cell injury โ enzyme leaks into blood. In macroamylasemia, amylase complexes with IgG/IgA โ unable to filter through kidney. |
| Diagnostic window | Rises within hours of onset; peaks ~24 h; returns to normal in 3โ5 days. |
| Clinical significance | โ ~75% of acute pancreatitis; also mumps, cholecystitis, hepatitis, ectopic pregnancy, intestinal infarction, perforation, trauma, opiates. |
| Assay method | Saccharogenic (measures glucose/maltose released) ยท Amyloclastic (decrease in starch) ยท Chromogenic (release of dye from starch). |
| Cam/Ccr ratio | Normal <3.1%; pancreatitis ~8โ9%; macroamylasemia <1%. Formula: 100 ร (UA/SA) ร (SC/UC). |
| Magnitude vs severity | NO correlation โ a “mild” amylase value does not mean mild disease. |
PRE-ANALYTICAL โ Amylase: Serum or heparinized plasma (NO citrate / oxalate / EDTA โ they chelate Caยฒโบ needed by the enzyme). Stable for ~7 days refrigerated. Hemolysis OK. Lipemia interferes with some assays. Urine collection 2โ24 h; refrigerate. Hyperlipidemia can cause spurious normal amylase (“Amylase Hidden by Lipids” pitfall).
2.3 Lipase โ The Specific Pancreas Marker
| Feature | Details |
|---|---|
| Tissue source | Almost exclusively pancreatic acinar cells (gastric lipase is minor, <17.5%). |
| Mechanism of elevation | Acinar leak; longer half-life and no salivary source = more SPECIFIC than amylase. |
| Diagnostic window | Rises as quickly as amylase; remains elevated LONGER โ often 8โ14 days. |
| Clinical significance | โ acute pancreatitis (preferred over amylase by many clinicians); also pancreatic CA, bowel infarction, bone fractures, fat embolism. |
| Cofactor requirement | Requires colipase + bile salts to bind triglyceride emulsion. |
| Specificity advantage | NOT elevated in mumps, salivary disease, or macroamylasemia. |
PRE-ANALYTICAL โ Lipase: Serum or heparinized plasma. Stable at room temperature 1 week; refrigerated longer. Hemolysis interferes (hemoglobin inhibits lipase). EDTA/oxalate not acceptable.
2.4 Sweat Chloride โ Cystic Fibrosis
| Feature | Details |
|---|---|
| Disorder | Cystic fibrosis โ autosomal recessive; CFTR gene on chromosome 7; >900 mutations described. |
| Mechanism | Defective Clโป channel โ sweat ducts can’t reabsorb Clโป โ sweat is salty. |
| Diagnostic cutoff | Children: sweat Clโป >60 mmol/L. Adults: >80 mmol/L. Borderline 40โ60. |
| Method | Pilocarpine iontophoresis โ electric current drives pilocarpine into skin โ stimulates sweat โ collected and analyzed for chloride. |
| Repeat | Always repeat a positive test on a separate occasion to confirm. |
| Limitations | Does NOT distinguish heterozygote carriers from normal homozygotes. |
| Other CF labs | Fecal elastase-1 โ (pancreatic insufficiency); IRT (immunoreactive trypsin) elevated in neonatal screen. |
PRE-ANALYTICAL โ Sweat Clโป: Minimum sample 75 mg (โฅ15 mg/mยฒ of collection area per 5 minutes). Forearm flexor surface preferred. Avoid eczematous skin. Adequate hydration required. Repeat all positives.
2.5 Fecal Fat โ Steatorrhea Quantification
| Feature | Details |
|---|---|
| Reference range | Adults 1โ7 g / 24 h. Lipid-free diet baseline: 1โ4 g/24 h. |
| Definition of steatorrhea | >5โ7 g fecal fat / 24 h. |
| Qualitative โ Sudan III | Stains neutral fats yellow-orange to red. Detects only droplets. Operator-dependent. |
| Quantitative โ gravimetric (van de Kamer) | 72-h collection on 100 g/d fat diet for โฅ2 days prior. Acidified, extracted, evaporated, weighed. Reference method. |
| Quantitative โ titrimetric | Saponify โ titrate fatty acids. Reads ~20% LOWER than gravimetric (misses unsaponifiable lipids). |
| Newer methods | Near-infrared reflectance, NMR, FTIR. |
PRE-ANALYTICAL โ Fecal Fat: 72-hour collection in tared NON-WAX container; refrigerate. Diet must contain 100 g fat/day for 2 days before AND during collection. NO castor oil / mineral oil / oily suppositories โค2 days before or during test. Total lipid stable 5 days refrigerated.
2.6 Fecal Elastase-1 โ Modern Pancreatic Insufficiency Test
| Feature | Details |
|---|---|
| Source | Pancreas-specific protease; concentration in stool is 5โ6ร higher than in pancreatic juice (not degraded in transit). |
| Method | ELISA with monoclonal antibodies to HUMAN elastase. |
| Key advantage | Pancreatic enzyme supplements (porcine) do NOT interfere โ antibody is human-specific. |
| Cutoffs | >200 ยตg/g = normal ยท 100โ200 = moderate insufficiency ยท <100 = severe. |
| Specimen | Single random stool sample (not 72-h collection). |
| Use | Method of choice for non-invasive assessment of exocrine pancreatic function; reliable in CF infants >2 weeks old. |
PRE-ANALYTICAL โ Fecal Elastase: Random formed stool best. WATERY stool gives FALSE-LOW results (dilution). Stable at room temperature 7 days; stable longer if frozen. Patient does NOT need to stop enzyme replacement therapy.
2.7 d-Xylose Absorption Test
| Feature | Details |
|---|---|
| Principle | d-Xylose is a pentose absorbed unchanged by the small bowel โ no pancreatic enzymes required โ tests INTESTINAL absorption only. |
| Dose | Adult: 25 g oral after overnight fast (drink water for next hour). Child: 0.5 g/kg. |
| Specimens | 5-hour urine collection + 2-hour blood (1-h in children). |
| Normal โ adult | 5-h urine excretion โฅ4 g; 2-h blood d-xylose โฅ25 mg/dL. |
| Normal โ child | Blood 1-h: โฅ15 mg/dL <6 mo, โฅ30 mg/dL older. |
| Method | Furfural reaction with p-bromoaniline (520 nm); thiourea added as antioxidant. |
| Interpretation | LOW d-xylose with steatorrhea = INTESTINAL malabsorption (celiac, sprue). NORMAL d-xylose with steatorrhea = PANCREATIC insufficiency. |
| Interferences | Aspirin โ renal excretion; indomethacin โ intestinal absorption. Bacterial overgrowth and renal failure give false-LOW. |
PRE-ANALYTICAL โ d-Xylose: Overnight fast; patient voids before dose. Blood in K-oxalate. No additional food/fluid until test complete. Complete urine collection essential โ incomplete collection mimics malabsorption.
2.8 Gastric Analysis โ Gastrin & Zรถllinger-Ellison
| Feature | Details |
|---|---|
| Gastric secretagogues | Vagal stimulation (sight/smell) ยท Gastric distention ยท Protein breakdown products ยท Gastrin (most potent). |
| Inhibitors | Low pH (negative feedback) ยท GIP ยท VIP ยท Secretin ยท Somatostatin. |
| Gastrin forms | G-17 (predominant after meals; tยฝ 6 min) ยท G-34 (predominant fasting; tยฝ 36 min). |
| Normal fasting gastrin | 50โ150 pg/mL. |
| ZE diagnostic | Fasting gastrin >1,000 pg/mL with gastric acid hypersecretion = virtually diagnostic. |
| Secretin stimulation | Normal: secretin DECREASES gastrin. ZE: PARADOXICAL โ โฅ100 pg/mL after IV secretin. |
| Basal/maximal ratio | ZE: basal output >10 mmol/h AND basal/max ratio >60%. |
| Pentagastrin | Synthetic pentapeptide, 6 ยตg/kg SC โ maximal stimulus (replaced histamine). |
| Pernicious anemia | Gastric atrophy โ pH won’t fall below 6 even with stimulation; gastrin elevated (lack of acid feedback). |
PRE-ANALYTICAL โ Gastrin: Fasting morning sample (gastrin rises post-meal). Stop PPI โฅ1 week and H2-blockers โฅ24 h before. Collect in tube with anticoagulant + protease inhibitor (aprotinin). Process rapidly; freeze plasma at โ20 ยฐC โ gastrin loses 50% immunoreactivity in 48 h at 2โ8 ยฐC.
2.9 Helicobacter pylori
| Feature | Details |
|---|---|
| Significance | Predominant cause of gastric and duodenal ulcers (โฅ95% of duodenal ulcers); risk factor for gastric adenocarcinoma (2โ10ร). |
| Survival mechanism | Produces UREASE โ hydrolyzes urea to bicarbonate + ammonia โ local alkaline microenvironment in acid stomach. |
| Urea breath test | Patient drinks ยนยณC-urea โ urease releases ยนยณCOโ โ exhaled โ detected by mass spec or IR. Sensitivity/specificity >95%. |
| Other non-invasive | Stool antigen test (monoclonal Ab); serology (cannot confirm eradication โ Ab persists). |
| Invasive | Gastric biopsy โ rapid urease test, histology (Giemsa), culture, PCR. |
| Confirm eradication | Urea breath test or stool antigen โฅ4 weeks after treatment. |
PRE-ANALYTICAL โ Urea Breath Test: Stop PPIs โฅ2 weeks before; H2-blockers โฅ24 h before. Antacids do NOT interfere. Fast 1 h before. Baseline breath collected, then collect 30โ45 min after ยนยณC-urea dose. PPIs cause false-NEGATIVES.
2.10 Celiac Disease
| Feature | Details |
|---|---|
| Autoantigen | Tissue transglutaminase (TGA) โ a calcium-dependent enzyme that deamidates gliadin. |
| Genetics | HLA-DQ2 in ~95%; remainder DQ8. DQ2 present in 20โ30% of whites but only ~1% develop disease. |
| Prevalence | ~1% of white populations; rare in East Asian / African. |
| Trigger | Gluten (gliadin) from wheat, barley, rye. A 33-AA gliadin peptide is the primary initiator. |
| Serology โ best | IgA anti-TGA (sensitivity >90%, specificity >99%); IgA anti-deamidated gliadin peptide (DGP) similar performance. |
| Critical rule | Measure total IgA first โ selective IgA deficiency (1 in 600) gives false-NEGATIVE on IgA tests; use IgG-DGP/TGA instead. |
| Monitoring | TGA titers fall on gluten-free diet; rise on dietary lapses. |
| Confirmation | Duodenal biopsy (villous atrophy + intraepithelial lymphocytosis). |
PRE-ANALYTICAL โ TGA: Patient must be CONSUMING GLUTEN at the time of testing โ gluten-free diet normalizes the antibody and gives false-NEGATIVES. Always order total IgA simultaneously.
2.11 Fecal Calprotectin โ IBD vs IBS
| Feature | Details |
|---|---|
| Source | S100A8/A9 heterodimer โ ~60% of neutrophil cytosolic protein. |
| Mechanism | Mucosal inflammation โ neutrophil migration โ shed into lumen โ into feces. |
| Cutoffs (typical) | <60 ยตg/g = IBS likely ยท 60โ150 = grey zone, retest ยท >150 = organic disease (IBD, CRC). |
| Performance | Sensitivity ~89%, specificity ~79% for IBD vs IBS. |
| Uses | Differentiate IBD from IBS; track disease activity; predict relapse; assess response to anti-TNF therapy. |
| Non-specific causes of elevation | NSAIDs, infection, colorectal cancer, diverticular disease. |
| Related markers | Lactoferrin (similar performance) ยท M2-PK (cellular turnover) ยท S100A12 (pediatric). |
PRE-ANALYTICAL โ Calprotectin: Single random stool. Stable at room temperature ~7 days; evenly distributed in stool so small portion OK. NSAIDs and PPIs can elevate. Discontinue NSAIDs โฅ1 week before if possible.
2.12 GI Regulatory Peptides โ Source & Function
| Hormone | Source Cell / Location | Trigger | Action |
|---|---|---|---|
| Gastrin (G-17 / G-34) | G cells โ gastric antrum / duodenum | Protein in stomach; vagal stim | โ HCl, โ pepsinogen, โ intrinsic factor, โ motility |
| Secretin | S cells โ duodenum | Acid (pH <4.5) in duodenum | โ pancreatic bicarbonate, โ gastric motility |
| Cholecystokinin (CCK) | I cells โ duodenum / jejunum | Fats + amino acids | โ pancreatic enzymes, โ gallbladder contraction, satiety signal |
| GIP (gastric inhibitory peptide / glucose-dependent insulinotropic peptide) | K cells โ duodenum / jejunum | Glucose, fat, amino acids | โ insulin release (incretin effect), โ gastric motility |
| VIP (vasoactive intestinal polypeptide) | Enteric nerves โ all GI tract | Vagal stim | Smooth muscle relaxation, โ water/electrolyte secretion. VIPoma โ WDHA syndrome. |
| Somatostatin | ฮด cells โ stomach, pancreas | Many stimuli (paracrine) | Universal INHIBITOR of GI hormones; somatostatinoma โ steatorrhea, gallstones, hyperglycemia. |
| Chromogranin A | All neuroendocrine secretory granules | โ | General marker for neuroendocrine tumors (sens >90%). |
KEY โ Neuroendocrine tumors: Gastrinoma โ ZE syndrome. VIPoma โ WDHA (Watery Diarrhea, Hypokalemia, Achlorhydria). Somatostatinoma โ steatorrhea + gallstones + diabetes. Chromogranin A elevated in all โ use it as a screening / monitoring marker (but it is also raised by PPIs and renal failure).
2.13 Disaccharidases & Brush Border Enzymes
| Enzyme | Substrate | Products | Deficiency Clue |
|---|---|---|---|
| Lactase (lactase-phlorizin hydrolase) | Lactose | Glucose + galactose | Milk โ bloating, diarrhea. Common (โฅ70% Asian/African adults). |
| Sucrase-isomaltase | Sucrose / 1,6-ฮฑ-bonds | Glucose + fructose / glucose | Diarrhea on sucrose-containing foods; rare in whites, โ in Inuit. |
| Trehalase | Trehalose | Glucose | Diarrhea after mushrooms. Common in Greenland (8%). |
| Glucoamylase-maltase | ฮฑ-1,4 oligosaccharides | Glucose | Rarely deficient alone. |
| Enterokinase (enteropeptidase) | Trypsinogen | Trypsin (then cascades all zymogens) | Deficiency โ severe protein malabsorption. |
| Monosaccharide transporters | SGLT1 (Naโบ-dependent, glucose + galactose) ยท GLUT5 (fructose, apical) ยท GLUT2 (basolateral, all 3) | โ | Glucose-galactose malabsorption (SGLT1 defect). |
SECTION 3 โ Visual Memory Hooks
๐ง “AmyLATE Lipase”: Amylase rises and falls FAST (peak 24 h, gone in 3โ5 days). Lipase rises just as fast but stays LATE โ up to 14 days. โ Order BOTH; lipase catches the late presenter.
๐ง “SECRETIN Sips, CCK Chomps”: Acid sips into duodenum โ SECRETIN โ bicarbonate. Food chomps in โ CCK โ enzymes + gallbladder squeeze.
๐ง “VIP throws a WDHA party”: VIPoma โ Watery diarrhea, Hypokalemia, Achlorhydria. (“VIP got the party going โ water, no potassium, no acid.”)
๐ง “d-Xylose Detects Direction”: Low d-xylose โ INTESTINAL disease. Normal d-xylose with steatorrhea โ PANCREATIC disease. (Xylose Xcuses the pancreas.)
๐ง “Macro 1, Pancreatitis 9”: Cam/Ccr ratio <1% = macroamylasemia (molecule too big to filter). ~9% = acute pancreatitis (kidney clears more amylase).
๐ง “7 = CF Cromosome”: CFTR gene โ chromosome 7. Sweat chloride cutoff: > 60 mmol/L for children.
๐ง “DQ2 โ Disease of Gluten”: 95% celiac = HLA-DQ2. Antibody = anti-tissue transglutaminase (TGA). Check total IgA first.
๐ง “ELASTAse lasts”: Fecal elastase-1 is stable through the gut AND through enzyme replacement therapy (porcine enzymes don’t cross-react with the human-specific antibody).
Pattern Triggers โ “If you see X โ think Y โ because Z”
| If you seeโฆ | Thinkโฆ | Becauseโฆ |
|---|---|---|
| โ Amylase + โ Lipase + hypocalcemia | Acute pancreatitis | Calcium is bound to free fatty acids generated by lipase |
| โ Serum amylase + normal urine amylase + Cam/Ccr <1% | Macroamylasemia | IgG-amylase complex too large for glomerulus |
| Recurrent peptic ulcers + diarrhea | Zรถllinger-Ellison (gastrinoma) | Hypergastrinemia โ acid floods small bowel + inactivates pancreatic enzymes |
| Salty-tasting child + chronic lung infections + bulky stools | Cystic fibrosis | CFTR defect โ mucus plugs + pancreatic insufficiency |
| Steatorrhea + LOW d-xylose | Intestinal malabsorption (celiac, sprue) | Mucosa can’t absorb even sugars that don’t need enzymes |
| Steatorrhea + NORMAL d-xylose | Pancreatic insufficiency | Mucosa intact; lack of pancreatic lipase causes fat loss |
| Chronic diarrhea + fecal calprotectin >150 | IBD (or CRC) โ colonoscope | Neutrophil migration into bowel lumen |
| Watery diarrhea + hypokalemia + achlorhydria | VIPoma (Verner-Morrison) | VIP โ secretory diarrhea + โ acid |
| Megaloblastic anemia + gastric pH won’t fall <6 | Pernicious anemia | Atrophic gastritis โ no IF, no acid, gastrin paradoxically up |
| Diarrhea after mushrooms | Trehalase deficiency | Mushrooms contain trehalose |
| Bleeding tendency in malabsorption | Vitamin K deficiency | Factors II, VII, IX, X are vitamin K-dependent |
Side-by-Side โ Confusing Pairs
| Feature | Acute Pancreatitis | Macroamylasemia |
|---|---|---|
| Serum amylase | โโโ (often >3ร ULN) | โ (chronic, modest) |
| Urine amylase | โโ | Normal or LOW |
| Cam/Ccr ratio | ~8โ9% | <1% |
| Lipase | โโโ | Normal |
| Symptoms | Severe pain, vomiting, shock | Asymptomatic / benign |
| Feature | Pancreatic Insufficiency | Intestinal Malabsorption (e.g., celiac) |
|---|---|---|
| d-Xylose absorption | NORMAL | LOW |
| Fecal elastase-1 | LOW (<200 ยตg/g) | Normal |
| Sudan III fecal fat | Heavy, with meat fibers | Heavy |
| Serum albumin | Usually preserved | Often <2.5 g/dL |
| TGA-IgA | Negative | Positive in celiac |
| Treatment | Enzyme replacement | Gluten-free diet (celiac) / specific therapy |
| Feature | Gastric Ulcer | Duodenal Ulcer | Zรถllinger-Ellison |
|---|---|---|---|
| Basal acid output | Normal / low | Often โ | >10 mmol/h |
| Maximal output | Normal | โ | Markedly โ |
| Basal/Max ratio | Normal | Normal | >60% |
| Fasting gastrin | Normal | Normal | >1,000 pg/mL |
| Secretin โ gastrin | โ slightly | โ slightly | PARADOXICAL โ โฅ100 pg/mL |
| H. pylori | Often + | โฅ95% + | ยฑ |
Diagnostic Window โ Time-Based Markers
| Marker | Onset | Peak | Duration / Returns to normal | Best Clinical Use |
|---|---|---|---|---|
| Serum amylase | 2โ12 h | ~24 h | 3โ5 days | Early acute pancreatitis |
| Serum lipase | 4โ8 h | ~24 h | 8โ14 days | Late-presenter acute pancreatitis (more specific than amylase) |
| Urine amylase | Hours after serum | 1โ3 days | 5โ10 days | Confirms / extends pancreatitis diagnosis |
| Gastrin (post-meal) | Minutes | 30โ60 min | tยฝ G-17 = 6 min; G-34 = 36 min | Secretin stimulation for ZE diagnosis |
| Urea breath test ยนยณCOโ | 15 min | 30โ45 min | Single measurement | H. pylori detection / eradication confirmation |
| Lactose Hโ breath | 30 min | 2โ3 h | 3โ5 h | Lactase deficiency |
| d-Xylose 2-h blood / 5-h urine | โ | 1โ2 h blood | 5 h urine | Intestinal vs pancreatic malabsorption |
SECTION 4 โ Diagnostic Flowcharts
Flowchart 1 โ Severe Epigastric Pain โ Acute Pancreatitis Workup
| ๐ก Patient with severe mid-epigastric pain radiating to back, nausea, vomiting |
| โ Order: serum amylase + lipase + Caยฒโบ + triglycerides + BUN + LFTs + glucose |
| โ Amylase >3ร ULN AND lipase elevated? |
| โ YES + hypocalcemia + hyperglycemia + โ BUN โ ACUTE PANCREATITIS |
| โ Look for cause: alcohol history? gallstones (ultrasound)? hypertriglyceridemia? hypercalcemia (hyperparathyroidism)? |
| โ NO with โ amylase only โ check urine amylase + Cam/Ccr ratio โ if ratio <1%, suspect macroamylasemia |
| โ ๏ธ Common mistake: ordering amylase alone late in disease โ by day 4โ5 amylase has normalized but lipase is still elevated. Order BOTH. |
Flowchart 2 โ Chronic Steatorrhea โ Localize the Lesion
| ๐ก Adult with bulky, foul, floating stools + weight loss |
| โ Confirm steatorrhea: 72-h fecal fat >7 g/day on 100 g/d fat diet |
| โ Order d-XYLOSE absorption test |
| โ d-Xylose NORMAL (โฅ4 g in 5 h urine) โ PANCREATIC cause โ confirm with fecal elastase-1 <200 ยตg/g โ workup CF (sweat Clโป), chronic pancreatitis (CT, MRCP), pancreatic CA |
| โ d-Xylose LOW โ INTESTINAL cause โ check TGA-IgA + total IgA (celiac), small bowel imaging, biopsy |
| โ Always check serum carotenoids (low in lipid malabsorption), PT (vit K deficiency), albumin (<2.5 g/dL favors intestinal disease) |
| โ ๏ธ Common mistake: diagnosing pancreatic disease from steatorrhea alone โ without d-xylose, you can’t tell. A NORMAL d-xylose with steatorrhea is the pancreas-locator. |
Flowchart 3 โ Refractory Peptic Ulcer โ Zรถllinger-Ellison Workup
| ๐ก Patient with multiple / recurrent / refractory ulcers ยฑ diarrhea |
| โ Stop PPI โฅ1 week โ draw fasting plasma gastrin |
| โ Gastrin >1,000 pg/mL with gastric acid hypersecretion โ virtually diagnostic of gastrinoma |
| โ Gastrin 150โ1,000 pg/mL โ IV SECRETIN STIMULATION |
| โ Gastrin rises โฅ100 pg/mL after secretin โ Zรถllinger-Ellison confirmed |
| โ Gastrin falls or unchanged โ ordinary peptic ulcer / PPI effect / pernicious anemia |
| โ Locate tumor: CT, MRI, endoscopic US, octreotide scan. Consider MEN1. |
| โ ๏ธ Common mistake: testing gastrin while patient is still on PPI โ chronic PPI use ALONE can raise gastrin to several hundred pg/mL โ false-positive. Stop PPI first. |
Flowchart 4 โ Suspected H. pylori โ Test Selection
| ๐ก Dyspepsia / suspected H. pylori in patient <55 with no alarm symptoms |
| โ Stop PPI โฅ2 weeks; H2-blockers โฅ24 h. Antacids OK. |
| โ Order urea breath test (ยนยณC) OR stool antigen test โ sens/spec >95% / 94% |
| โ Positive โ eradication therapy โ recheck with urea breath test or stool antigen โฅ4 weeks after treatment |
| โ Endoscopy reserved for age โฅ55 with new-onset persistent dyspepsia, alarm features, or treatment failure |
| โ DO NOT use serology to confirm eradication โ IgG antibodies persist for months/years |
| โ ๏ธ Common mistake: negative urea breath test while patient is on PPI โ false-negative. Always verify PPI washout. |
Flowchart 5 โ Chronic Diarrhea โ IBD vs IBS Triage (Calprotectin)
| ๐ก Adult with chronic diarrhea (>4 weeks) |
| โ Rule out infection (stool culture, O&P, C. difficile) |
| โ Order CBC, CRP, TGA-IgA + total IgA (celiac), TSH, fecal calprotectin |
| โ Calprotectin <60 ยตg/g โ IBS likely; apply Rome criteria โ reassure + manage |
| โ Calprotectin 60โ150 ยตg/g โ consider NSAIDs, infection, retest in 4โ6 weeks |
| โ Calprotectin >150 ยตg/g โ organic disease โ refer for colonoscopy (IBD, CRC) |
| โ ๏ธ Common mistake: ordering calprotectin while patient is on NSAIDs โ they can raise calprotectin and cause false-positives. Document recent NSAID use. |
SECTION 5 โ 25 High-Yield Facts
| # | Fact |
|---|---|
| 1 | The pancreas secretes 1.5โ2 L/day of alkaline (pH up to 8.3), bicarbonate-rich juice. |
| 2 | Acinar cells make digestive enzymes; islets of Langerhans make insulin, glucagon, gastrin, somatostatin. |
| 3 | Secretin โ bicarbonate; CCK โ enzymes. “Acid asks for buffer, fat asks for enzymes.” |
| 4 | Enterokinase (duodenal brush border) converts trypsinogen to trypsin, which activates all other pancreatic zymogens. |
| 5 | Serum amylase rises 2โ12 h, peaks ~24 h, normalizes in 3โ5 days in acute pancreatitis. |
| 6 | Lipase rises as quickly as amylase but stays elevated up to 14 days โ more specific. |
| 7 | Cam/Ccr ratio: normal <3.1%; acute pancreatitis ~8โ9%; macroamylasemia <1%. |
| 8 | Hypocalcemia in pancreatitis = calcium soap formation by free fatty acids liberated by lipase. |
| 9 | Cystic fibrosis: autosomal recessive, CFTR on chromosome 7; sweat Clโป >60 mmol/L diagnostic in children. |
| 10 | Pilocarpine iontophoresis is the standard sweat induction technique. |
| 11 | Steatorrhea = fecal fat >5 g/24 h; reference range 1โ7 g/24 h. |
| 12 | Fecal fat is collected over 72 h on a 100 g/day fat diet; NO oily laxatives or mineral oil for 2 days prior. |
| 13 | Titrimetric fecal fat reads ~20% lower than gravimetric (misses unsaponifiable lipids). |
| 14 | Sudan III stains neutral fats yellow-orange in qualitative screening. |
| 15 | Fecal elastase-1 <200 ยตg/g = pancreatic insufficiency; NOT affected by enzyme replacement therapy. |
| 16 | d-Xylose absorption is normal in pancreatic disease and LOW in intestinal mucosal disease โ it’s the locator test. |
| 17 | Gastrin is most potent gastric acid stimulus; secreted by G cells of antrum and duodenum. |
| 18 | Parietal cells secrete HCl AND intrinsic factor; chief cells secrete pepsinogen. |
| 19 | Zรถllinger-Ellison: fasting gastrin >1,000 pg/mL; basal/max acid ratio >60%; secretin causes PARADOXICAL rise (โฅ100 pg/mL). |
| 20 | Pernicious anemia: gastric pH won’t fall below 6 with stimulation; intrinsic factor deficient โ Bโโ malabsorption. |
| 21 | H. pylori urea breath test uses ยนยณC-urea (non-radioactive); urease releases ยนยณCOโ. Stop PPI โฅ2 weeks. |
| 22 | Celiac disease: anti-tissue transglutaminase IgA (TGA-IgA) is the screening test; ~95% express HLA-DQ2. |
| 23 | Always check total IgA when testing for celiac โ IgA deficiency causes false-negative TGA-IgA. |
| 24 | Fecal calprotectin (S100A8/9) >150 ยตg/g = organic disease (IBD, CRC); <60 ยตg/g supports IBS. |
| 25 | Lactose Hโ breath test: rise >20 ppm above fasting at 2 h = lactase deficiency; has replaced lactose tolerance test. |
๐ฏ EXAM TIP โ The single most testable pattern in this chapter:
“Steatorrhea + LOW d-xylose = INTESTINAL disease. Steatorrhea + NORMAL d-xylose = PANCREATIC disease.”
If you see d-xylose mentioned in any malabsorption scenario, the question is testing this exact concept โ guaranteed.
“Steatorrhea + LOW d-xylose = INTESTINAL disease. Steatorrhea + NORMAL d-xylose = PANCREATIC disease.”
If you see d-xylose mentioned in any malabsorption scenario, the question is testing this exact concept โ guaranteed.
Quick Interpretation Table
| Lab Finding | Clinical Interpretation |
|---|---|
| โโ Amylase + โโ Lipase + โ Caยฒโบ + โ BUN | Acute pancreatitis |
| โ Serum amylase + normal urine amylase + Cam/Ccr <1% | Macroamylasemia (benign) |
| Sweat Clโป >60 mmol/L in a child | Cystic fibrosis |
| Fasting gastrin >1,000 pg/mL + paradoxical โ after secretin | Zรถllinger-Ellison syndrome |
| Gastric pH won’t fall below 6 + low Bโโ + macrocytic anemia | Pernicious anemia |
| Low d-xylose absorption + low carotenoids + โ fecal fat + โ PT | Intestinal malabsorption (e.g., celiac) |
| Normal d-xylose + โ fecal fat + low fecal elastase-1 | Pancreatic exocrine insufficiency |
| Fecal calprotectin >150 ยตg/g | Organic disease โ IBD or CRC; needs colonoscopy |
SECTION 5B โ Interactive Flashcards (Active Recall)
SECTION 6 โ Practice Quiz (10 Patient Scenarios)
SECTION 7 โ Trap Questions (7 Examiner Pitfalls)
๐ด Critical Numbers
- Pancreas: 70โ105 g; juice 1.5โ2 L/day; pH up to 8.3
- Bicarbonate + Clโป in pancreatic juice โ 150 mmol/L
- Steatorrhea: >5 g fecal fat / 24 h
- Fecal fat reference: 1โ7 g / 24 h
- Sweat Clโป cutoff (child): >60 mmol/L
- Sweat Clโป cutoff (adult): >80 mmol/L
- Fecal elastase-1: <200 ยตg/g = insufficiency; <100 = severe
- d-Xylose 5-h urine: โฅ4 g normal (adult, 25 g dose)
- d-Xylose 2-h blood: โฅ25 mg/dL normal (adult)
- Cam/Ccr normal <3.1%; pancreatitis ~8โ9%; macro <1%
- Fasting gastrin normal 50โ150 pg/mL; ZE >1,000
- Secretin test ZE: gastrin โ โฅ100 pg/mL
- ZE basal acid output >10 mmol/h; basal/max >60%
- Calprotectin: <60 normal ยท >150 organic
- Lactose Hโ breath: rise >20 ppm = positive
๐ต Pattern Associations
- CFTR โ chromosome 7
- Sweat Clโป โ pilocarpine iontophoresis
- Celiac โ HLA-DQ2 (95%) + TGA-IgA
- H. pylori โ urease โ ยนยณC-urea breath
- VIPoma โ WDHA syndrome
- Gastrinoma โ ZE syndrome + MEN1
- Calprotectin โ S100 family โ neutrophils
- Lactase โ phlorizin hydrolase complex
- Trehalase โ mushrooms
- Hartnup โ phenylalanine + leucine transport
- Glucose/galactose โ SGLT1 ; fructose โ GLUT5
- Chromogranin A โ neuroendocrine tumors
- Pernicious anemia โ intrinsic factor โ Bโโ
- S cells โ secretin ; G cells โ gastrin ; I cells โ CCK ; K cells โ GIP
๐ Opposites โ What Goes Up vs Down
- Acute pancreatitis: โ amylase, โ lipase, โ glucose, โ BUN; โ Caยฒโบ, โ albumin
- Pernicious anemia: โ gastrin, โ pH; โ intrinsic factor, โ Bโโ
- ZE syndrome: โโ gastrin, โโ acid; gastrin โ AFTER secretin (paradox)
- Intestinal malabsorption: โ d-xylose, โ carotenoids, โ albumin (<2.5), โ PT
- Pancreatic insufficiency: โ fecal elastase; d-xylose NORMAL
- VIPoma: โ stool water; โ Kโบ, โ gastric acid (achlorhydria)
- Somatostatinoma: โ glucose, โ steatorrhea, โ gallstones
- Macroamylasemia: โ serum amylase; โ urine amylase; Cam/Ccr โ
๐ฃ Confusing Pairs โ Don’t Mix Up
- Amylase peak vs lipase peak: both ~24 h, but lipase lasts 14 days vs amylase 3โ5 days
- Cam/Ccr direction: pancreatitis HIGH (~9%); macroamylasemia LOW (<1%)
- Secretin response: normal LOWERS gastrin; ZE RAISES gastrin (paradox)
- d-Xylose: tests intestine ONLY; normal = pancreas-cause; low = bowel-cause
- Fecal chymotrypsin vs elastase: elastase NOT degraded in transit, NOT affected by enzyme supplements (anti-human Ab)
- Gravimetric vs titrimetric fecal fat: titrimetric reads ~20% lower
- Gastric vs duodenal ulcer acid output: gastric normal/low, duodenal โ
- HLA-DQ2 (celiac) vs HLA-B27 (AS) vs HLA-DR4 (RA, T1DM)
- TGA-IgA test: needs gluten in diet AND requires checking total IgA first
- SGLT1 (Naโบ-dependent, glucose/galactose) vs GLUT5 (fructose, apical) vs GLUT2 (basolateral)
- Secretin = bicarbonate; CCK = enzymes
๐ข Methods Cheat Sheet
- Sweat Clโป โ pilocarpine iontophoresis
- H. pylori โ ยนยณC-urea breath test
- Lactase deficiency โ Hโ breath test (replaced lactose tolerance)
- Pancreatic insufficiency โ fecal elastase-1 (ELISA)
- Gold standard pancreatic function โ secretin-CCK intubation test
- Bile acid malabsorption โ SeHCAT (or serum C4 / FGF-19)
- Celiac โ TGA-IgA ELISA + total IgA
- IBD vs IBS โ fecal calprotectin (S100A8/9)
- Pancreatic imaging gold standard โ spiral CT with contrast
- Biliary tree non-invasive โ MRCP
- d-Xylose โ furfural + p-bromoaniline (520 nm, thiourea antioxidant)
- Fecal fat (quantitative reference) โ 72-h gravimetric (van de Kamer)
SECTION 9 โ Final Memory Map
โฃ Pancreatic, Gastric & Intestinal Function
โ Pancreas
โข Endocrine: insulin, glucagon, gastrin, somatostatin (islets)
โข Exocrine: 1.5โ2 L/d alkaline juice; pH up to 8.3; HCOโโป + Clโป โ 150 mmol/L
โข Enzymes: proteolytic (trypsin, chymotrypsin, elastase), lipolytic (lipase + colipase, lecithinase), amylase, nucleases
โข Activation: enterokinase โ trypsin โ cascade
โข Control: secretin (โ HCOโโป); CCK (โ enzymes)
โ Pancreatic Disease
โข Acute pancreatitis: โโ amylase + lipase, โ Caยฒโบ, โ BUN; alcohol + gallstones leading causes
โข Chronic pancreatitis: alcohol; fecal elastase low; imaging shows calcification
โข Pancreatic carcinoma: head โ painless jaundice + clay stools + cholestatic LFTs
โข Cystic fibrosis: CFTR chr 7; sweat Clโป >60 child; pilocarpine iontophoresis
โ Pancreatic Function Tests
โข Amylase: Cam/Ccr ratio formula 100 ร (UA/SA) ร (SC/UC); normal <3.1%; pancreatitis ~9%; macro <1%
โข Lipase: more specific, longer half-life, requires colipase + bile salts
โข Fecal elastase-1 (non-invasive method of choice); unaffected by enzyme replacement
โข Secretin-CCK test (gold standard, invasive)
โข 72-h fecal fat (gravimetric reference)
โ Stomach
โข Parietal cells: HCl + intrinsic factor (Bโโ binding)
โข Chief cells: pepsinogen โ pepsin (acidic activation)
โข G cells (antrum): gastrin (G-17 tยฝ 6 min; G-34 tยฝ 36 min)
โข Inhibitors: low pH, GIP, VIP, secretin, somatostatin
โ Gastric Disorders
โข Zรถllinger-Ellison: gastrin >1,000; basal/max ratio >60%; paradox secretin โ โ gastrin โฅ100 pg/mL
โข Pernicious anemia: gastric pH won’t fall <6; Bโโ โ; gastrin paradoxically โ
โข H. pylori: urease โ ยนยณC-urea breath test; โฅ95% duodenal ulcers; risk of gastric CA
โ Small Intestine
โข Villi/microvilli โ 600ร surface area โ ~250 mยฒ
โข Disaccharidases: lactase, sucrase-isomaltase, maltase, trehalase, glucoamylase
โข Transporters: SGLT1 (Na+-dep glucose/galactose), GLUT5 (fructose, apical), GLUT2 (basolateral)
โข Lipid absorption: micelles โ enterocyte โ chylomicrons โ lymphatics
โ Intestinal Disorders
โข Celiac disease: gluten + DQ2 (95%); TGA-IgA + check total IgA
โข Lactase deficiency: Hโ breath test rise >20 ppm
โข Bacterial overgrowth: glucose Hโ breath test, early rise
โข Bile acid malabsorption: SeHCAT (or C4, FGF-19)
โข IBD vs IBS: fecal calprotectin (S100A8/9); >150 = organic
โข Protein-losing enteropathy: fecal ฮฑโ-antitrypsin (AAT)
โข Hartnup syndrome: phe + leu transporter defect
โ GI Regulatory Peptides
โข Gastrin (G) โ HCl; Secretin (S) โ HCOโโป; CCK (I) โ enzymes + gallbladder + satiety; GIP (K) โ insulin; VIP (nerves) โ vasodilate + secretion; Somatostatin (ฮด) โ universal inhibitor
โข Tumor syndromes: gastrinoma โ ZE; VIPoma โ WDHA; somatostatinoma โ steatorrhea + DM + gallstones; chromogranin A = pan-NE marker
โ Imaging
โข Spiral CT with contrast โ gold standard for pancreas
โข MRCP โ non-invasive pancreatic duct + biliary tree
โข Endoscopic US โ small NE tumors, cystic lesions, duct stones